Detalhe da pesquisa
1.
Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice.
Cell
; 185(9): 1572-1587.e11, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35452622
2.
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.
Nature
; 586(7830): 567-571, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32756549
3.
Increased neutralization potency and breadth elicited by a SARS-CoV-2 mRNA vaccine forming virus-like particles.
Proc Natl Acad Sci U S A
; 120(29): e2305896120, 2023 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37428933
4.
Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2.
Sci Transl Med
; 15(713): eadf4100, 2023 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37703353
5.
Omicron variant Spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccines.
Sci Transl Med
; 14(642): eabn9243, 2022 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35289637
6.
Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domains.
bioRxiv
; 2022 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36238717
7.
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness.
bioRxiv
; 2020 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32577634